NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
BigBear.ai Holdings
BBAI
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
KPTI Karyopharm Therapeutics
- 7.950
- -0.400-4.79%
Close Feb 28 16:00 ET
- 7.950
- 0.0000.00%
Post 20:01 ET
66.91MMarket Cap-0.57P/E (TTM)
8.700High7.885Low120.80KVolume8.700Open8.350Pre Close969.49KTurnover1.66%Turnover RatioLossP/E (Static)8.42MShares25.50052wk High-0.36P/B57.98MFloat Cap7.60552wk Low--Dividend TTM7.29MShs Float735.075Historical High--Div YieldTTM9.76%Amplitude7.605Historical Low8.025Avg Price1Lot Size
Karyopharm Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.55%145.24M | -9.50%30.54M | 7.70%38.78M | 13.86%42.79M | -14.40%33.13M | -7.03%146.03M | 0.50%33.75M | -0.38%36.01M | -5.29%37.58M | -18.82%38.7M |
| Operating revenue | -0.55%145.24M | -9.50%30.54M | 7.70%38.78M | 13.86%42.79M | -14.40%33.13M | -7.03%146.03M | 0.50%33.75M | -0.38%36.01M | -5.29%37.58M | -18.82%38.7M |
| Cost of revenue | 21.55%6.01M | -10.43%1.33M | 42.70%1.3M | 22.70%1.47M | 41.45%1.91M | -5.20%4.94M | -20.45%1.49M | -7.04%911K | 27.16%1.19M | -5.26%1.35M |
| Gross profit | -1.32%139.23M | -9.45%29.21M | 6.80%37.48M | 13.57%41.32M | -16.42%31.22M | -7.09%141.09M | 1.73%32.26M | -0.19%35.1M | -6.08%36.39M | -19.24%37.35M |
| Operating expense | -4.42%258.67M | -13.67%60.49M | -3.91%63.77M | 5.28%69.44M | -4.79%64.97M | -7.97%270.63M | 6.84%70.07M | 0.54%66.36M | -19.22%65.96M | -15.57%68.25M |
| Selling and administrative expenses | -12.47%115.44M | -11.40%27.19M | -10.30%27.63M | -9.89%31.07M | -17.71%29.55M | -9.30%131.88M | -11.43%30.69M | -11.08%30.81M | -7.65%34.48M | -7.38%35.91M |
| -General and administrative expense | -12.47%115.44M | -11.40%27.19M | -10.30%27.63M | -9.89%31.07M | -17.71%29.55M | --131.88M | --30.69M | -11.08%30.81M | -7.65%34.48M | -7.38%35.91M |
| Research and development costs | 3.23%143.23M | -15.44%33.3M | 1.63%36.13M | 21.90%38.37M | 9.54%35.43M | -6.67%138.75M | 27.31%39.38M | 13.37%35.55M | -28.96%31.48M | -23.12%32.34M |
| Operating profit | 7.79%-119.44M | 17.26%-31.28M | 15.92%-26.28M | 4.91%-28.12M | -9.26%-33.76M | 8.90%-129.54M | -11.63%-37.81M | -1.37%-31.26M | 31.08%-29.57M | 10.66%-30.9M |
| Net non-operating interest income expense | -133.09%-30.02M | -163.61%-9.72M | -187.48%-9.55M | -137.13%-7.02M | -28.15%-3.73M | 43.10%-12.88M | 18.96%-3.69M | 39.09%-3.32M | 50.83%-2.96M | 55.99%-2.91M |
| Non-operating interest income | -32.38%7.4M | -41.19%1.48M | -33.38%1.83M | -31.66%1.93M | -24.32%2.16M | 363.88%10.94M | 88.91%2.52M | 317.93%2.75M | 863.82%2.82M | 3,750.00%2.85M |
| Non-operating interest expense | 57.08%37.42M | 80.48%11.2M | 87.47%11.39M | 54.72%8.95M | 2.19%5.88M | -4.69%23.82M | 5.49%6.21M | -0.67%6.07M | -8.38%5.78M | -13.85%5.76M |
| Other net income (expense) | 20,633.71%73.1M | 4,893.36%10.11M | 4,160.67%3.79M | 196,560.00%59M | 174.24%196K | -328.92%-356K | -1,523.08%-211K | 456.25%89K | 330.77%30K | -261.64%-264K |
| Special income (charges) | --44.7M | --0 | --0 | --44.7M | ---- | --0 | --0 | --0 | --0 | ---- |
| -Less:Other special charges | ---44.7M | --0 | ---- | ---44.7M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | 8,076.97%28.4M | 4,893.36%10.11M | 4,160.67%3.79M | 47,553.33%14.3M | 174.24%196K | -328.92%-356K | -1,523.08%-211K | 456.25%89K | 330.77%30K | ---264K |
| Income before tax | 46.51%-76.37M | 25.94%-30.89M | 7.10%-32.04M | 173.41%23.86M | -9.45%-37.29M | 13.43%-142.78M | -8.52%-41.71M | 4.92%-34.49M | 33.59%-32.5M | 17.44%-34.07M |
| Income tax | -82.35%57K | -183.85%-109K | 133.33%28K | -47.24%67K | 31.48%71K | -12.47%323K | 78.08%130K | -73.33%12K | 4.96%127K | -58.46%54K |
| Net income | 46.60%-76.42M | 26.43%-30.78M | 7.05%-32.07M | 172.91%23.79M | -9.48%-37.36M | 13.43%-143.1M | -8.65%-41.84M | 5.00%-34.51M | 33.49%-32.63M | 17.57%-34.13M |
| Net income continuous Operations | 46.60%-76.42M | 26.43%-30.78M | 7.05%-32.07M | 172.91%23.79M | -9.48%-37.36M | 13.43%-143.1M | -8.65%-41.84M | 5.00%-34.51M | 33.49%-32.63M | 17.57%-34.13M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 46.60%-76.42M | 26.43%-30.78M | 7.05%-32.07M | 172.91%23.79M | -9.48%-37.36M | 13.43%-143.1M | -8.65%-41.84M | 5.00%-34.51M | 33.49%-32.63M | 17.57%-34.13M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 5.54M | |||||||||
| Net income attributable to common stockholders | 46.60%-76.42M | 26.43%-30.78M | 7.05%-32.07M | 155.93%18.25M | -9.48%-37.36M | 13.43%-143.1M | -8.65%-41.84M | 5.00%-34.51M | 33.49%-32.63M | 17.57%-34.13M |
| Basic earnings per share | 49.60%-9.45 | 33.33%-3.6 | 13.33%-3.9 | 151.72%2.25 | -6.67%-4.8 | 38.12%-18.75 | 16.28%-5.4 | 33.33%-4.5 | 53.23%-4.35 | 43.40%-4.5 |
| Diluted earnings per share | 25.60%-13.95 | 33.33%-3.6 | 13.33%-3.9 | 31.03%-3 | -6.67%-4.8 | 38.12%-18.75 | 16.28%-5.4 | 33.33%-4.5 | 53.23%-4.35 | 43.40%-4.5 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |